February 13, 2008 – MEDRAD Inc. delivered the 10,000th Mark V ProVis Angiography Injection System, which is used worldwide for live imaging during therapeutic interventions and diagnostic angiography procedures, demonstrating consistent demand for the system in cardiology, interventional radiology and vascular surgery despite a trend toward noninvasive CT and MR for diagnostic procedures.
MEDRAD’s latest generation injection system for live imaging, the MEDRAD Avanta Fluid Management Injection System, provides fixed or variable flow contrast and saline delivery on-demand, replacing the manual manifold and syringe. By enhancing digital fluoroscopy with operator-controlled contrast injections, workflow is improved and contrast consumption is reduced, says the manufacturer.
Physicians have traditionally used angiography injectors to inject contrast media into the arterial system of a patient through a catheter to help them see and diagnose vascular disease. While noninvasive modalities are rapidly becoming preferred for diagnosis, angiography injectors are fundamentally necessary to perform “live imaging” during therapeutic interventions such as angioplasty or the placement of stents.
Find more information: www.bayerhealthcare.com and www.medrad.com
February 12, 2026 
